Publication | Open Access

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

ThrombosisTenecteplase Versus AlteplaseCardiovascular DiseaseIschemic StrokeMedicineCerebrovascular DiseaseParallel GroupRehabilitationNeurologyCerebrovascular InterventionCerebral Blood FlowAcute StrokeStrokeNeurological AssessmentPublic HealthIschemic Syndrome